Bemdaneprocel
AssetAlso BRT-DA01, MSK-DA01, DA01
Pluripotent stem cell-derived dopaminergic neuron progenitor cell therapy
- Stage
- Phase 3
- Modality
- Cell therapy
- Target
- Stem cell maintenance
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Parkinson's disease
Phase 3, bluerocktx.com, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors3
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.